✦ LIBER ✦

PCN89 Economic Evaluation of Erlotinib as Treatment of or Metastasic Cancer of Non-Small Cell Lung Cancer (NSCLC) Prior Chemotherapy in Mexico

✍ Scribed by Lechuga, D.; Alva, M.; Sanchez-Kobashi, R.; Gay, J.G.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN34 PHARMAECONOMIC EVALUATION OF THE U

✍ C Tenorio; J Vargas; MI Pacheco; L González-Michaca 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PCN12 COST EFFECTIVENESS OF ERLOTINIB IN

✍ E Orlewska; A Szczesna; M Gyldmark; M Szkultecka-Debek 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

Systemic chemotherapy as a primary treat

✍ Lee, J.S; Pisters, K.M; Komaki, R; Terry, K; Glisson, B.S; Perez-Soler, R; Fosse 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 139 KB

PCN77 COST-EFFECTIVENESS ANALYSIS OF ERL

✍ TE Ciuleanu; M Dediu; LN Minea; S Baculea; M Szkultecka-Debek 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PCN145 HEALTH ECONOMIC REVIEW OF NON-SMA

✍ J Munakata; K Trochlil; DS Battleman; D Foley 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

PCN76 Economic Evaluation of the Use of

✍ Lechuga, D.; Alva, M.; Gay, J.G.; Sánchez-Kobashi, R. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB